Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report

Immunotherapy has improved outcomes in many malignancies, most notably in melanoma, lung cancer, and bladder cancer. Understanding the side effects associated with these medications is an important part of managing our patients. Although fatigue, rash, and diarrhea are commonly reported side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Muralikrishnan, Sivraj, Ronan, Lara K., Coker, Shodeinde, Rauschkolb, Paula K., Shirai, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036588/
https://www.ncbi.nlm.nih.gov/pubmed/32110218
http://dx.doi.org/10.1159/000504930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036588/
https://www.ncbi.nlm.nih.gov/pubmed/32110218
http://dx.doi.org/10.1159/000504930

Ejemplares similares